ArticleJournal of investigative medicine high impact case reports

Belzutifan, HIF-2α Inhibitor, and Clear Cell Renal Cell Carcinoma With Somatic Von-Hippel-Lindau Loss-of-Function Mutation.

Kok Hoe Chan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.